BSX Boston Scientific Corporation
Boston Scientific Corporation (BSX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $14.9M.
Where they traded
Last open-market purchase: August 25, 2026 , by Morano Susan E .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Morano Susan E | Director | Buy | 2,040 | $49.22 | $100.4K | 13,784 | |
| Habiger David C | Director | Buy | 2,100 | $47.59 | $99.9K | 17,160 | |
| Habiger David C | Director | Buy | 140 | $48.59 | $6.8K | 15,060 | |
| Mahoney Michael F | Chairman, President & CEO | Buy | 186,240 | $48.33 | $9.0M | 1,590,024 | |
| Habiger David C | Director | Buy | 1,042 | $48.07 | $50.1K | 14,920 | |
| LUDWIG EDWARD J | Director | Buy | 5,000 | $45.48 | $227.4K | 30,359 | |
| LUDWIG EDWARD J | Director | Buy | 3,580 | $56.68 | $202.9K | 25,359 | |
| Habiger David C | Director | Buy | 2,250 | $55.92 | $125.8K | 13,878 | |
| Pegus Cheryl | Director | Buy | 1,770 | $56.49 | $100.0K | 1,770 | |
| Habiger David C | Director | Buy | 2,200 | $56.95 | $125.3K | 11,628 | |
| Mahoney Michael F 2 fills | Chairman, President & CEO | Sell 10b5-1 | 160,901 | $93.49 | $15.0M | 1,571,436 −9.3% of holding | |
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | Sell 10b5-1 | 17,313 | $101.55 | $1.8M | 23,600 −42.3% of holding | |
| Zane Ellen M | Director | Sell 10b5-1 | 12,891 | $98.28 | $1.3M | 24,134 −34.8% of holding | |
| Fitzgerald Joseph Michael 3 fills | EVP & Group Pres, Cardiology | Sell 10b5-1 | 50,000 | $99.47 | $5.0M | 224,742 −18.2% of holding | |
| Zane Ellen M | Director | Sell 10b5-1 | 2,901 | $102.24 | $296.6K | 24,134 −10.7% of holding | |
| Zane Ellen M | Director | Sell 10b5-1 | 9,990 | $101.13 | $1.0M | 27,035 −27% of holding | |
| Fitzgerald Joseph Michael 2 fills | EVP & Group Pres, Cardiology | Sell 10b5-1 | 50,000 | $98.47 | $4.9M | 220,097 −18.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.